By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Elan Pharmaceuticals (South San Francisco, CA) 

800 Gateway Boulevard

South San Francisco  California  94080  U.S.A.
Phone: 650-877-7647 Fax: 650-877-7669


Elan Corporation, plc is a neuroscience-based biotechnology company that is focused on discovering, developing, manufacturing and marketing advanced therapies in neurology, autoimmune diseases and severe pain.

Click here to visit the Career section!

Key Statistics

Ownership: Public

Web Site: Elan Pharmaceuticals
Symbol: ELN


Company News
Elan Pharmaceuticals (ELN) Reports Second Quarter and First Half 2013 Financial Results 7/24/2013 6:35:25 AM
Elan Pharmaceuticals (ELN) Lab Liquidation Auctions -- South San Francisco Closure; to be Hosted by BioSurplus on Its Secure Online Auction Platform 1/9/2013 9:42:25 AM
Elan Pharmaceuticals (ELN) Hoping Alzheimer's Drug Will "Transform" Firm 5/25/2012 7:55:40 AM
Elan Pharmaceuticals (ELN) to Present at the Leerink Swann 2012 Global Healthcare Conference 2/2/2012 6:19:42 AM
Intellect Neurosciences, Inc. Files Appeal in Europe in Response to Opposition Proceedings Instituted by Elan Pharmaceuticals (ELN) and Wyeth (WYE)/Pfizer Inc. (PFE) 12/15/2011 10:55:05 AM
Elan Pharmaceuticals (ELN) Presents 7th Annual Danville Concours d'Elegance Weekend 8/30/2011 5:50:01 AM
Elan Pharmaceuticals (ELN) Pays Transition Therapeutics Inc. (TTH.TO) $9M in Amended Deal for Phase II Alzheimer Candidate; Transition Eligible for $11 Million More 12/27/2010 7:40:40 AM
Lundbeck Inc. (formerly Ovation Pharmaceuticals) CFO: Elan Pharmaceuticals (ELN) Not an Acquisition Option Now 5/13/2009 11:26:23 AM
Elan Corporation PLC (ELN)'s Tysabri May Reverse MS Damage, Shares Up 4/29/2009 7:28:54 AM
Intellect Neurosciences, Inc. Grants to Top Tier Global Pharmaceutical Company an Option to License Certain Alzheimer's Patents and Patent Applications 10/8/2008 8:57:49 PM